Evidence map›Paper›PMID 36012568›Full record

ArticleInternational journal of molecular sciences2022

Role of the WNT/β-catenin/ZKSCAN3 Pathway in Regulating Chromosomal Instability in Colon Cancer Cell lines and Tissues.

Young-Eun Cho, Jeong-Hee Kim, Young-Hyun Che, Yong-Jun Kim, Ji-Youn Sung, Yoon-Wha Kim, Bong-Geun Choe, Sun Lee, Jae-Hoon Park

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Epigenetic silencingCancer biology & therapy · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Effect of Lacking ZKSCAN3 on Autophagy, Lysosomal Biogenesis and Senescence.International journal of molecular sciences · 2023
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Young-Eun ChoDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Jeong-Hee KimDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Young-Hyun CheDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Yong-Jun KimDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.ORCID 0000-0002-5374-712X
Ji-Youn SungDepartment of Pathology, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID 0000-0002-6607-2117
Yoon-Wha KimDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Bong-Geun ChoeDepartment of Preventive Medicine, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Sun LeeDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.ORCID 0000-0003-1717-2557
Jae-Hoon ParkDepartment of Pathology, College of Medicine, Kyung Hee University, Seoul 02453, Korea.
Kyung Hee University · KR

Funding

National Research Foundation of Korea 2020R1F1A1076390
6 · The paper itself

Abstract

Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3) acts as an oncogenic transcription factor in human malignant tumors, including colon and prostate cancer. However, most of the ZKSCAN3-induced carcinogenic mechanisms remain unknown. In this study, we identified ZKSCAN3 as a downstream effector of the oncogenic Wnt/β-catenin signaling pathway, using RNA sequencing and ChIP analyses. Activation of the Wnt pathway by recombinant Wnt gene family proteins or the GSK inhibitor, CHIR 99021 upregulated ZKSCAN3 expression in a β-catenin-dependent manner. Furthermore, ZKSCAN3 upregulation suppressed the expression of the mitotic spindle checkpoint protein, Mitotic Arrest Deficient 2 Like 2 (MAD2L2) by inhibiting its promoter activity and eventually inducing chromosomal instability in colon cancer cells. Conversely, deletion or knockdown of ZKSCAN3 increased MAD2L2 expression and delayed cell cycle progression. In addition, ZKSCAN3 upregulation by oncogenic WNT/β-catenin signaling is an early event of the adenoma-carcinoma sequence in colon cancer development. Specifically, immunohistochemical studies (IHC) were performed using normal (NM), hyperplastic polyps (HPP), adenomas (AD), and adenocarcinomas (AC). Their IHC scores were considerably different (61.4 in NM; 88.4 in HPP; 189.6 in AD; 246.9 in AC). In conclusion, ZKSCAN3 could be responsible for WNT/β-catenin-induced chromosomal instability in colon cancer cells through the suppression of MAD2L2 expression.

Indexed as

AdenocarcinomaChromosomal InstabilityColonic NeoplasmsWnt Signaling Pathwaybeta CateninCarcinogenesisCell LineCell Line, TumorGene Expression Regulation, NeoplasticHumansMad2 ProteinsMaleTranscription Factorsbeta CateninMAD2L2 protein, humanMad2 ProteinsTranscription FactorsZKSCAN3 protein, humancolon cancerMAD2L2WNTZKSCAN3β-catenin

Identifiers

PMID36012568
PMCPMC9409321
OpenAlexW4292246853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.